| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study. | Cancer | 1995 | 0.93 |
| 2 | How schools perceive the school health service. | Public Health | 1991 | 0.80 |